amantadine hydrochloride
Commercial- Indications
- Parkinson's disease
Company intelligence / Profile preview
Apeloa operates at commercial scale as one of China’s top exporters of APIs and among the top 5 small molecule CDMOs. Its manufacturing sites have passed audits by major global regulatory agencies including the US FDA and EMEA. The company supports global pharmaceutical clients with both generic APIs/intermediates and finished dosage forms. It has established advanced R&D capabilities in flow chemistry and biocatalysis to support innovative drug development for partners. No proprietary clinical-stage pipeline was identified.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apeloa.